G.A.M. Krekels

3.2k total citations
44 papers, 2.1k citations indexed

About

G.A.M. Krekels is a scholar working on Epidemiology, Dermatology and Oncology. According to data from OpenAlex, G.A.M. Krekels has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 25 papers in Dermatology and 14 papers in Oncology. Recurrent topics in G.A.M. Krekels's work include Nonmelanoma Skin Cancer Studies (33 papers), Cancer and Skin Lesions (15 papers) and Cutaneous Melanoma Detection and Management (11 papers). G.A.M. Krekels is often cited by papers focused on Nonmelanoma Skin Cancer Studies (33 papers), Cancer and Skin Lesions (15 papers) and Cutaneous Melanoma Detection and Management (11 papers). G.A.M. Krekels collaborates with scholars based in Netherlands, United States and Finland. G.A.M. Krekels's co-authors include Judith U. Ostertag, Carmen D. Dirksen, Brigitte A.B. Essers, Nicole W. J. Smeets, H. A. Martino Neumann, Klara Mosterd, Fred Nieman, Patricia J.F. Quaedvlieg, Peter M. Steijlen and Monique R.T.M. Thissen and has published in prestigious journals such as The Lancet, The Lancet Oncology and Journal of the American Academy of Dermatology.

In The Last Decade

G.A.M. Krekels

44 papers receiving 2.0k citations

Peers

G.A.M. Krekels
G.A.M. Krekels
Citations per year, relative to G.A.M. Krekels G.A.M. Krekels (= 1×) peers Massimiliano Scalvenzi

Countries citing papers authored by G.A.M. Krekels

Since Specialization
Citations

This map shows the geographic impact of G.A.M. Krekels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.A.M. Krekels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.A.M. Krekels more than expected).

Fields of papers citing papers by G.A.M. Krekels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.A.M. Krekels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.A.M. Krekels. The network helps show where G.A.M. Krekels may publish in the future.

Co-authorship network of co-authors of G.A.M. Krekels

This figure shows the co-authorship network connecting the top 25 collaborators of G.A.M. Krekels. A scholar is included among the top collaborators of G.A.M. Krekels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.A.M. Krekels. G.A.M. Krekels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veta, Mitko, et al.. (2021). Whole‐slide margin control through deep learning in Mohs micrographic surgery for basal cell carcinoma. Experimental Dermatology. 30(5). 733–738. 28 indexed citations
2.
Geer, Simone van der, et al.. (2015). Development of a Non-Melanoma Skin Cancer Detection Model. Dermatology. 230(2). 161–169. 5 indexed citations
3.
Mosterd, Klara, G.A.M. Krekels, Marieke H. Roozeboom, et al.. (2014). Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10year follow-up. European Journal of Cancer. 50(17). 3011–3020. 215 indexed citations
4.
Mosterd, Klara, Brigitte A.B. Essers, Anja Sommer, et al.. (2013). Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. The Lancet Oncology. 14(7). 647–654. 196 indexed citations
5.
Geer, Simone van der, Jasper M. Martens, E. Brand, et al.. (2012). Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study. British Journal of Dermatology. 167(1). 110–115. 19 indexed citations
6.
Dellaert, Nico, et al.. (2012). Admission and capacity planning for the implementation of one-stop-shop in skin cancer treatment using simulation-based optimization. Health Care Management Science. 16(1). 75–86. 29 indexed citations
7.
Geer, Simone van der, Hajo A. Reijers, H.F.J.M. van Tuijl, Hein de Vries, & G.A.M. Krekels. (2010). Need for a New Skin Cancer Management Strategy. Archives of Dermatology. 146(3). 332–6. 25 indexed citations
8.
Mosterd, Klara, G.A.M. Krekels, Fred Nieman, et al.. (2008). Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. The Lancet Oncology. 9(12). 1149–1156. 302 indexed citations
9.
Thissen, Monique R.T.M., D.I.M. Kuijpers, & G.A.M. Krekels. (2006). Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.. PubMed. 5(5). 461–4. 18 indexed citations
10.
Ostertag, Judith U., Patricia J.F. Quaedvlieg, Anton H. M. Vermeulen, et al.. (2006). Congenital naevi treated with erbium:YAG laser (Derma K) resurfacing in neonates: clinical results and review of the literature. British Journal of Dermatology. 154(5). 889–895. 30 indexed citations
11.
Quaedvlieg, Patricia J.F., David Creytens, Carine J. Peutz‐Kootstra, et al.. (2006). Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips. Histopathology. 49(3). 256–264. 58 indexed citations
12.
Ostertag, Judith U., Patricia J.F. Quaedvlieg, Simone van der Geer, et al.. (2006). A clinical comparison and long‐term follow‐up of topical 5‐fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses. Lasers in Surgery and Medicine. 38(8). 731–739. 31 indexed citations
13.
Essers, Brigitte A.B., Fred Nieman, Martin H. Prins, et al.. (2005). Determinants of satisfaction with the health state of the facial skin in patients undergoing surgery for facial basal cell carcinoma. Patient Education and Counseling. 60(2). 179–186. 15 indexed citations
14.
Tilli, C.M.L.J., Maurice A. M. Van Steensel, G.A.M. Krekels, Harald Neumann, & F.C.S. Ramaekers. (2005). Molecular aetiology and pathogenesis of basal cell carcinoma. British Journal of Dermatology. 152(6). 1108–1124. 100 indexed citations
15.
Smeets, Nicole W. J., et al.. (2003). Adjuvant Cytokeratin Staining in Mohs Micrographic Surgery for Basal Cell Carcinoma. Dermatologic Surgery. 29(4). 375–377. 21 indexed citations
16.
Quaedvlieg, Patricia J.F., Judith U. Ostertag, G.A.M. Krekels, & H. A. Martino Neumann. (2003). Delayed Wound Healing After Three Different Treatments for Widespread Actinic Keratosis on the Atrophic Bald Scalp. Dermatologic Surgery. 29(10). 1052–1056. 17 indexed citations
17.
Field, Lawrence M., et al.. (2002). Cervicomental "Turkey Gobbler": A New Source for Full-Thickness Grafts. Dermatologic Surgery. 28(4). 353–355. 2 indexed citations
18.
Krekels, G.A.M., M.E.J.M. Verhaegh, Sjoerd Sc. Wagenaar, F. C. S. Ramaekers, & Harald Neumann. (2000). Keratins (K8 and K19) as potential markers of recurrent basal cell carcinoma. European Journal of Dermatology. 7(3). 158–160. 5 indexed citations
19.
Krekels, G.A.M., et al.. (2000). DNA-protection by sunscreens: p53-immunostaining. European Journal of Dermatology. 7(4). 259–262. 1 indexed citations
20.
Verhaegh, M.E.J.M., et al.. (1997). [Mohs' method of micrographic surgery as treatment for recurrent basal cell carcinoma].. PubMed. 141(11). 524–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026